Target intelligence / Profile preview

Spalt-like transcription factor 3 (SALL3)

Target
SALL3
Molecular classification
Transcription factor, C2H2-type zinc finger protein
01

Overview

Spalt-like transcription factor 3 (SALL3) is a member of the evolutionarily conserved SALL family of C2H2-type zinc finger transcription factors. SALL3 regulates gene expression by binding to AT-rich regions in DNA via its zinc finger motifs, most notably interacting with DNA methyltransferase 3A (DNMT3A) to reduce CpG island methylation. Loss or silencing of SALL3 increases DNMT3A activity, leading to aberrant DNA methylation and potentially contributing to oncogenesis, especially in hepatocellular carcinoma. SALL3 also serves as a determinant of lineage commitment in stem cell differentiation, with its expression biasing pluripotent stem cells toward ectodermal rather than mesodermal or endodermal fates. Mutations in SALL3 and related family members are associated with congenital disorders, emphasizing this protein's importance during embryonic development.

Other names
Sal-like protein 3SALL3ZNF796hSALL3Zinc finger protein 796Zinc finger protein SALL3C2H2 zinc finger protein SALL3epididymis secretory sperm binding proteinspalt-like zinc finger proteinzinc finger protein 796
02

Biological functions

Regulation of DNA methylationEmbryonic developmentModulation of cell differentiationRegulation of epigenetic stateTranscriptional regulation
03

Disease associations

Congenital disorders (e.g., Ivic Syndrome, Townes-Brocks Syndrome)Cancer (notably hepatocellular carcinoma)Developmental abnormalities
04

Biomarkers

Differentiation propensity marker in induced pluripotent stem cellsPossible marker for hepatocellular carcinoma progression

Beyond the preview

Go deeper on Spalt-like transcription factor 3 (SALL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spalt-like transcription factor 3 (SALL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call